InvestorsHub Logo

north40000

11/22/16 3:11 PM

#337 RE: DewDiligence #336

Perhaps, some mutual implant problems? But the 2 themselves do not account for XBI, BBH, IBB, FBT indices being well down, as I write. Take a look at JNJ, PFE, MRK, CELG, GILD as well, for example, also LABU.

NAFTA, TPTA concerns also?

We will see if a recovery occurs at/near close. CNBC said biotech sector is still +9% for the month.

inversor86

11/22/16 3:43 PM

#338 RE: DewDiligence #336

http://seekingalpha.com/news/3226466-device-makers-feel-medtronics-pain

Investors' sour mood with Medtronic (MDT -10.2%) over its modest 2% fiscal Q2 revenue miss has spread to Abbott (ABT -4.6%), Edwards Lifesciences (EW -5.6%) and Boston Scientific (BSX -4.4%).

Others feeling the pinch are Stryker (SYK -2.3%) and C.R. Bard (BCR -3.6%).

inversor86

11/24/16 1:03 AM

#340 RE: DewDiligence #336

Perhaps also some dissatisfaction with their new debt offering.